First Merchants Corp’s Edwards Lifesciences EW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$222K Sell
2,840
-200
-7% -$15.6K 0.01% 332
2025
Q1
$220K Sell
3,040
-7,405
-71% -$537K 0.01% 345
2024
Q4
$773K Sell
10,445
-60,491
-85% -$4.48M 0.03% 247
2024
Q3
$4.68M Sell
70,936
-1,539
-2% -$102K 0.18% 126
2024
Q2
$6.69M Sell
72,475
-1,396
-2% -$129K 0.27% 92
2024
Q1
$7.06M Sell
73,871
-981
-1% -$93.7K 0.53% 61
2023
Q4
$5.71M Sell
74,852
-2,182
-3% -$166K 0.47% 73
2023
Q3
$5.34M Buy
77,034
+508
+0.7% +$35.2K 0.48% 74
2023
Q2
$7.22M Buy
76,526
+3,340
+5% +$315K 0.61% 54
2023
Q1
$6.05M Buy
73,186
+850
+1% +$70.3K 0.54% 65
2022
Q4
$5.4M Buy
72,336
+14,213
+24% +$1.06M 0.49% 70
2022
Q3
$4.8M Buy
58,123
+4,158
+8% +$344K 0.48% 68
2022
Q2
$5.13M Buy
53,965
+1,697
+3% +$161K 0.51% 64
2022
Q1
$6.15M Buy
52,268
+1,551
+3% +$183K 0.5% 67
2021
Q4
$6.57M Sell
50,717
-281
-0.6% -$36.4K 0.51% 63
2021
Q3
$5.77M Sell
50,998
-4,145
-8% -$469K 0.37% 67
2021
Q2
$5.71M Sell
55,143
-1,141
-2% -$118K 0.37% 71
2021
Q1
$4.71M Buy
56,284
+2,750
+5% +$230K 0.31% 81
2020
Q4
$4.88M Buy
53,534
+1,122
+2% +$102K 0.34% 71
2020
Q3
$4.18M Buy
52,412
+5,786
+12% +$462K 0.32% 76
2020
Q2
$3.22M Buy
46,626
+288
+0.6% +$19.9K 0.27% 92
2020
Q1
$2.91M Buy
46,338
+5,127
+12% +$322K 0.38% 84
2019
Q4
$3.21M Buy
41,211
+1,320
+3% +$103K 0.33% 94
2019
Q3
$2.92M Sell
39,891
-3,633
-8% -$266K 0.31% 99
2019
Q2
$2.68M Buy
43,524
+8,451
+24% +$520K 0.43% 84
2019
Q1
$2.24M Buy
35,073
+2,949
+9% +$188K 0.36% 91
2018
Q4
$1.64M Buy
32,124
+1,914
+6% +$97.7K 0.31% 99
2018
Q3
$1.75M Buy
30,210
+3,012
+11% +$175K 0.29% 105
2018
Q2
$1.32M Buy
27,198
+6,072
+29% +$295K 0.23% 119
2018
Q1
$982K Buy
+21,126
New +$982K 0.16% 132